医疗器械公司Artivion(AORT)周一盘后交易中大跌6.64%,因公司最新公布的第四季度业绩未达分析师预期。
数据显示,Artivion第四季度销售额为9731万美元,较去年同期增长3.88%,但低于分析师预期的1.0082亿美元。季绩不佳导致资金撤离,引发Artivion盘后股价暴跌。
分析人士指出,医疗器械行业竞争激烈,如果Artivion未来无法实现预期销售增长,将对公司业绩和股价造成进一步压力。市场将持续关注Artivion后续财报,评估其业务发展势头。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.